Effect of longer battery life on small bowel capsule endoscopy

Table 2 Basic Information n (%)

Variable	All (n = 408)	SB2 (n = 186)	SB2U (n = 222)	P value
Male	208 (51.0)	93 (50.0)	115 (51.8)	0.717
Age				0.602
Mean ± SD	55.5 ± 19.3	56.6 ± 17.3	54.6 ± 20.9
Median (IQR)	60.0 (44.0, 70.0)	59.5 (47.0, 69.0)	60.0 (41.0, 70.0)
Range	(9.0, 90.0)	(15.0, 90.0)	(9.0, 88.0)
Indication				0.051
Gastrointestinal bleeding	254 (62.3)	121 (65.1)	133 (59.9)
Inflammatory bowel disease	86 (21.1)	29 (15.6)	57 (25.7)
Abdominal pain, radiological abnormality, history of obstruction	47 (11.5)	23 (12.4)	24 (10.8)
Others1	21 (5.1)	13 (7.0)	8 (3.6)
Inpatient	20 (4.9)	8 (4.3)	12 (5.4)	0.607
Previous abdominal/pelvic surgery	171 (41.9)	83 (44.6)	88 (39.6)	0.310
Use of narcotics or prokinetics				0.641
None	371 (90.9)	168 (90.3)	203 (91.4)
Narcotics	33 (8.1)	17 (9.1)	16 (7.2)
Prokinetics	4 (1.0)	1 (0.5)	3 (1.4)
Bowel habit				0.848
Normal	342 (83.8)	154 (82.8)	188 (84.7)
Constipation	14 (3.4)	8 (4.3)	6 (2.7)
Diarrhea	41 (10.0)	19 (10.2)	22 (9.9)
Alternating	11 (2.7)	5 (2.7)	6 (2.7)
Connective tissue disease	16 (3.9)	9 (4.8)	7 (3.2)	0.382
Diabetes mellitus	73 (17.9)	28 (15.1)	45 (20.3)	0.171
Charlson index score (unadjusted for age)				0.819
Mean ± SD	1.0 ± 1.6	1.0 ± 1.5	1.1 ± 1.7
Median (IQR)	0.0 (0.0, 2.0)	0.0 (0.0, 2.0)	0.0 (0.0, 2.0)
Range	(0.0, 10.0)	(0.0, 7.0)	(0.0, 10.0)

¹Polyposis syndrome, cancer/lymphoma screening/surveillance, abnormal bowel movement, reflux, pancytopenia, refractory celiac disease, recurrent vomiting. IQR: Interquartile range; SD: Standard deviation.